Browse by Audience
Skip to content
Papers of the Week
The ultimate guide to the anti-CGRP monoclonal antibodies galaxy.
Authors
Abstract
Anti-CGRP monoclonal antibodies have represented a real revolution in the field of headaches, being the result of an extraordinary process of translation of new pathophysiological discoveries into successful therapies. Nonetheless, clinical practice is far more complex than pivotal trials setting, and real-world studies are blooming to deepen knowledge of these revolutionary medications.